HLA- B27 Test for Ankylosing Spondylitis at Dr. Essa Lab

HLA- B27 at Dr. Essa Lab

The HLA- B27 test is a highly specialized molecular and immunological diagnostic investigation designed to detect the presence of the Human Leukocyte Antigen B27 on the surface of white blood cells. Human Leukocyte Antigens (HLAs) are proteins encoded by the major histocompatibility complex (MHC) gene family located on chromosome 6. These surface proteins play an indispensable role in the human immune system, helping defense cells distinguish between self-proteins and foreign invaders such as bacteria, viruses, and toxins. Among these antigens, HLA- B27 is a specific class I surface glycoprotein that has been strongly linked to a group of chronic inflammatory joint diseases collectively known as seronegative spondyloarthropathies. At Dr. Essa Lab, this test is performed using state-of-the-art diagnostic technologies, including flow cytometry and polymerase chain reaction (PCR), ensuring the highest levels of analytical sensitivity and clinical specificity for patients across Karachi and Pakistan.

Understanding the clinical importance of the HLA- B27 antigen is crucial for both clinicians and patients. While the presence of this antigen is not a standalone diagnosis for any disease, it serves as an invaluable genetic marker that significantly increases the likelihood of developing certain autoimmune and inflammatory conditions. The diagnostic value of this test lies in its high negative predictive value; a negative result makes a diagnosis of HLA- B27-associated spondyloarthropathies highly unlikely. Conversely, a positive result, when correlated with clinical symptoms such as chronic lower back pain, joint stiffness, and ocular inflammation, provides strong supportive evidence for conditions like Ankylosing Spondylitis, Reactive Arthritis, and Acute Anterior Uveitis. By choosing Dr. Essa Lab for this critical investigation, patients benefit from precise, reproducible results that form the cornerstone of early therapeutic intervention and personalized rheumatological care.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for the HLA- B27 blood test is straightforward, as it does not require extensive lifestyle modifications. However, adhering to the following guidelines ensures a seamless testing experience at Dr. Essa Lab:

• No Fasting Required: Unlike routine metabolic panels, you do not need to fast before this test. You may eat and drink normally prior to your appointment.
• Medication Disclosure: Inform your prescribing physician and the laboratory staff about all medications you are currently taking, especially immunosuppressants, corticosteroids, or biologics, though they typically do not alter genetic marker expression.
• Hydration: Drink plenty of water before the procedure. Well-hydrated veins are easier to locate, making the venipuncture process quicker and more comfortable.
• Comfortable Clothing: Wear a short-sleeved shirt or clothing with sleeves that can be easily rolled up above the elbow to allow clear access to the venipuncture site.
• Identification and Documents: Bring your doctor’s referral slip, national identity card, and any previous diagnostic reports relevant to your condition.

During the Procedure

The HLA- B27 test is a standard venipuncture procedure performed by highly trained phlebotomists at Dr. Essa Lab. The entire process takes approximately 5 to 10 minutes and follows strict aseptic protocols:

• Patient Positioning: You will be asked to sit comfortably in a specialized phlebotomy chair. The phlebotomist will inspect your arm to identify the most suitable vein, typically located in the antecubital fossa (the bend of the elbow).
• Sanitization: The selected area is thoroughly cleansed with an antiseptic swab (usually 70% isopropyl alcohol) to eliminate surface bacteria and prevent infection.
• Tourniquet Application: A soft elastic band is tied around your upper arm to temporarily restrict blood flow, causing the veins to swell and become more visible and accessible.
• Sample Collection: A sterile, single-use needle attached to a vacuum collection tube (typically containing EDTA or ACD anticoagulant) is gently inserted into the vein. You may feel a brief, mild pinch or stinging sensation as the needle enters.
• Tube Filling: The blood flows naturally into the collection tube. Once the required volume of blood is collected, the tourniquet is released to restore normal circulation.
• Post-Puncture Care: The needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote clotting and minimize bruising. A small adhesive bandage is then applied.
• Safety Considerations: All materials used during the procedure are immediately disposed of in biohazard containers in compliance with international biosafety standards, ensuring zero risk of cross-contamination.

When is a HLA- B27 Performed?

Evaluation of Suspected Ankylosing Spondylitis

Ankylosing Spondylitis (AS) is a chronic, progressive inflammatory arthritis that primarily affects the spine and sacroiliac joints, leading to eventual joint fusion and severe rigidity. Physicians frequently order the HLA- B27 test when a patient presents with persistent, inflammatory lower back pain that has lasted for more than three months, especially if the pain begins before the age of 40, worsens during periods of inactivity, and improves significantly with physical exercise. Detecting the HLA- B27 marker assists rheumatologists in confirming AS in its early stages, often before characteristic structural damage becomes visible on conventional X-rays.

Investigation of Reactive Arthritis (Reiter’s Syndrome)

Reactive Arthritis is an inflammatory joint condition that develops in response to an infection originating in another part of the body, typically the gastrointestinal or genitourinary tract. The classic triad of symptoms includes urethritis, conjunctivitis, and asymmetric arthritis (often summarized as “can’t see, can’t pee, can’t climb a tree”). Because a high percentage of patients with severe or chronic Reactive Arthritis carry the HLA- B27 genetic marker, clinicians utilize this test to assess the risk of disease chronicity, predict potential recurrences, and differentiate it from other forms of acute arthritis.

Assessment of Acute Anterior Uveitis

Acute Anterior Uveitis is a painful inflammatory condition affecting the iris and ciliary body of the eye, presenting with symptoms such as sudden ocular redness, intense pain, photophobia (sensitivity to light), and blurred vision. Since HLA- B27 is strongly associated with isolated anterior uveitis, ophthalmologists and rheumatologists routinely request this test for patients experiencing recurrent episodes of eye inflammation. Identifying the presence of this marker helps clinicians recognize the systemic nature of the ocular disease and monitor the patient for subsequent joint manifestations.

Diagnosis of Psoriatic Arthritis and Enteropathic Arthropathy

Psoriatic arthritis (associated with the skin condition psoriasis) and enteropathic arthropathy (associated with Inflammatory Bowel Diseases like Crohn’s disease and Ulcerative Colitis) frequently present with spinal involvement resembling ankylosing spondylitis. When patients with known skin or bowel disorders develop axial joint pain, physicians order the HLA- B27 test to evaluate the genetic predisposition to spinal inflammation. This helps in tailoring targeted therapeutic regimens, such as tumor necrosis factor (TNF) inhibitors, which are highly effective in HLA- B27-associated axial diseases.

Differentiation of Seronegative Spondyloarthropathies

In clinical practice, distinguishing between various forms of joint pain can be challenging, particularly when routine autoimmune panels (such as Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide) return negative results. This group of disorders is termed “seronegative” because they lack these classic rheumatoid markers. The HLA- B27 test serves as a pivotal diagnostic tool in these scenarios, helping clinicians categorize the patient’s condition under the spondyloarthritis spectrum rather than rheumatoid arthritis or osteoarthritis, thereby avoiding inappropriate treatments.

What Does a HLA- B27 Detect?

The HLA- B27 test is designed to detect specific genetic and molecular markers associated with systemic inflammatory diseases. The test evaluates and helps identify:

• The presence of the HLA- B27 surface antigen on white blood cells (Positive result).
• The absence of the HLA- B27 surface antigen (Negative result).
• Genetic predisposition to Ankylosing Spondylitis.
• Increased risk for the development of Reactive Arthritis following bacterial infections.
• A genetic link to recurrent Acute Anterior Uveitis (eye inflammation).
• Predisposition to Psoriatic Arthritis with axial (spinal) involvement.
• Susceptibility to Enteropathic Arthritis associated with Crohn’s disease or Ulcerative Colitis.
• Supportive evidence for Juvenile Idiopathic Arthritis (specifically enthesitis-related arthritis) in pediatric patients.
• The underlying cause of chronic, unexplained sacroiliitis (inflammation of the sacroiliac joints).
• An explanation for persistent morning stiffness lasting more than 30 minutes in young adults.
• A hereditary pattern of spondyloarthropathies within families.
• The likelihood of developing extra-articular manifestations of spondyloarthritis, such as aortitis or pulmonary fibrosis.
• Supportive data for the diagnosis of undifferentiated spondyloarthritis in symptomatic patients.
• A high negative predictive value, helping rule out HLA- B27-associated autoimmune conditions when symptoms are ambiguous.
• The presence of genetic markers that may influence the severity and progression of spinal inflammation.
• Risk stratification for patients presenting with heel pain (enthesitis of the Achilles tendon).
• The necessity for early referral to a rheumatologist for specialized joint-sparing therapies.
• Correlation with radiographic findings of syndesmophytes (bony growths) along the spine.
• The potential genetic basis for chest wall pain resulting from costovertebral joint inflammation.
• Information that guides the selection of advanced biologic therapies, such as IL-17 or TNF inhibitors.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for diagnostic results can be an anxious time for patients and their families. Because the HLA- B27 test involves sophisticated molecular techniques or flow cytometry to ensure absolute accuracy, the processing time is managed with the utmost efficiency. Typically, the verified reports for the HLA- B27 test are completed and authorized by our consultant pathologists within 24 to 48 hours of sample collection.

Dr. Essa Lab offers multiple convenient pathways for patients to access their diagnostic reports. Once your report is finalized, you will receive an automated SMS notification containing a direct link to download your electronic report. Additionally, patients can securely access, view, and print their results through the official Dr. Essa Lab web portal or the dedicated mobile application. Physical copies of the report can also be collected from any of our conveniently located diagnostic centers across the city.

HLA- B27 Findings Overview

The following table outlines the clinical parameters evaluated during the HLA- B27 test, along with their normal and abnormal clinical implications:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HLA- B27 Antigen Status	Negative (Antigen not detected on cell surfaces)	Positive (Antigen detected on cell surfaces)
Sacroiliac Joint Correlation	No inflammation or joint space narrowing	Bilateral or unilateral sacroiliitis, joint erosion
Spinal Column Assessment	Normal vertebral alignment and flexibility	Syndesmophyte formation, spinal fusion (“bamboo spine”)
Ocular Inflammatory Risk	Clear ocular structures, no uveitis	Recurrent acute anterior uveitis, iris congestion
Gastrointestinal Association	Normal bowel mucosa and function	Inflammatory Bowel Disease-associated arthropathy
Entheses (Tendon Insertions)	No pain or inflammation at tendon sites	Enthesitis (e.g., Achilles tendonitis, plantar fasciitis)
Rheumatoid Factor (RF) Status	Negative (Typical for seronegative spondyloarthritis)	Positive (Suggests co-existing or alternative RA diagnosis)
Pediatric Joint Assessment	Normal childhood joint development	Enthesitis-related Juvenile Idiopathic Arthritis

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for HLA- B27?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified consultant pathologists, molecular biologists, and technologists specializing in immunological testing.
• Patient-Focused Care: We prioritize patient comfort and dignity, ensuring a compassionate, stress-free environment during sample collection.
• Quality Diagnostic Services: Dr. Essa Lab adheres to stringent international quality control standards, ensuring highly reproducible and clinically reliable test results.
• Professional Reporting: Our diagnostic reports are detailed, clear, and structured to provide clinicians with the precise information needed for accurate decision-making.
• Modern Diagnostic Approach: We utilize advanced flow cytometry and PCR technologies to minimize false positives and false negatives.
• Comfortable Environment: All our collection centers are designed to be clean, hygienic, and welcoming for patients of all ages.
• Convenient Location: With an extensive network of branches across Karachi and other major cities, accessing our services is highly convenient.
• Commitment to Accurate Diagnosis: For over three decades, Dr. Essa Lab has remained a trusted name in healthcare, dedicated to supporting clinical diagnoses with integrity and precision.